Scheme 1. (A) Late-Stage Site-Selective Diversification of Vancomycin. (B) MIC Values (μg/mL) for Vancomycin Derivatives. (C) Selected Natural Products for Late-Stage Diversification via Site-Selective Transformation of Reactive Functional Groups.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.